Cadrenal Therapeutics, Inc. SEC filings CVKD

Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Aug 3, 2026 —
DEF 14A Proxy statement Aug 3, 2026 Sep 24, 2026
PRE 14A Preliminary proxy statement Jul 23, 2026 Jul 23, 2026
DEFA14A Additional proxy material Jul 31, 2025 —
DEF 14A Proxy statement Jul 31, 2025 Sep 24, 2025
DEFA14A Additional proxy material Jun 12, 2024 —
DEF 14A Proxy statement Jun 11, 2024 Jul 29, 2024
PRE 14A Preliminary proxy statement May 29, 2024 May 29, 2024
DEFA14A Additional proxy material Aug 31, 2023 —
DEFA14A Additional proxy material Aug 31, 2023 —
DEF 14A Proxy statement Aug 28, 2023 Oct 20, 2023

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CVKD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ponte Vedra, FL
SEC filer status
, Emerging growth company
SEC CIK
1937993

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.